Shalby Ltd - 540797 - Resumption Of Admission Of Patients (Non-Covid Patients) At Shalby Multi-Specialty Hospital, Indore - Regulation 30 Of SEBI (LODR)
Resumption of admission of patients (Non-CoVID Patients) at Shalby Multi-specialty Hospital, Indore Shalby Ltd - 540797 - Submission Of Certificate Under Regulation 40(9) & 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For Half Year Ended March 31, 2020
Submission of Certificate under Regulation 40(9) & 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for half year ended March 31, 2020 Shalby Ltd - 540797 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShalby Ltd 2CINL85110GJ2004PLC044667 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 62.22 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jayesh Patel Designation: Company Secretary and Compliance Officer EmailId: companysecretary@shalby.in Name of the Chief Financial Officer: Prahlad Rai Inani Designation: Chief Financial Officer EmailId: cfo@shalby.org Date: 28/05/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Conference call hosted by Centrum Broking Ltd (Investors / Analysts) on 19th May 2020 to discuss impact of COVID-19 and likely recovery of hospital sector in ongoing COVID-19 pandemic. Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Conference call with Investors / Analysts on 4th May 2020 with Xponentia Fund Shalby Ltd - 540797 - Starting Of Treatment Of COVID-19 Patient At Shalby Hospital (Naroda) And Shalby Hospital (Vijay Cross-Navrangpura) Both In Ahmedabad
Starting of treatment of COVID-19 patient at Shalby Hospital (Naroda) and Shalby Hospital (Vijay Cross-Navrangpura) both in Ahmedaba Shalby Ltd - 540797 - Shareholding for the Period Ended March 31, 2020
Shalby Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here Shalby Ltd - 540797 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Shalby Ltd - 540797 - Compliance Certificate Under Reg. 7(3) Of SEBI LODR For Half Year Ended March 31, 2020
Compliance Certificate under Reg. 7(3) of SEBI LODR for half year ended March 31, 2020 Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference call with Investors / Analysts on 16th April 2020 to discuss current scenario and impact on the healthcare industry in connection with the ongoing COVID-19 pandemic